LOW AFFINITY ADSORBENT FOR AFFINITY CHROMATOGRAPHY

Abstract: The invention relates to a high performance affinity chromatographic system characterized by an immobilized active substance interacting weakly (K diss >10⁻³ M) with the desired structure of the type or types of molecule to be separated. The substance is covalently bound in its active state on a carrier of a solid, preferably porous, organic or inorganic material thereby making it suitable for use in the so-called HPLC or HPLAC technique for the separation of e.g. biomolecules. Examples of useful inorganic materials are silica or glass, or organic materials such as plastics or polysaccharides. Separation takes place by the mobile liquid being led through the column packed with the immobilized active substance of weak affinity for the complementary substances. Examples of such immobilized ligands are antibodies or fragments thereof, antigens or fragments thereof and various receptor substances.

Description: State of the art Affinity chromatography is a method of separation by which the substance or substances to be separated (ligates) are made to interact specifically and reversibly with a complementary substance (ligand) which is bound while in its active state to a stationary, solid phase. In practice, a movable liquid phase containing the substances to be separated is allowed to pass a solid phase with bound ligands, the separation thereby taking place by the desired substances being specifically adsorbed on the stationary phase, while other types of molecules will pass. The desired substances are finally eluated by employing various chemical and physical methods. In this manner it has been possible to purify in one single step the actual substance a great number of times (10-100). One of the first applications of affinity chromatography was associated with the purification of α-amylase on insoluble starch (Starkenstein, Biochem. Z., 24 (1910) 210). Not until the end of the 1960's, however, affinity chromatography was established as a method of separation in connection with the Axén synthesis of activated gels (Axén et al., Nature 214 (1967) 1302) and the Cuatrecasas (J. Biol. Chem. 245 (1970) 3059) works on interaction between a bound ligand and a reversible desirable substance. Parallel with these advancements, the traditional liquid chromatography was subjected to rapid development. The utilization of extremely small-sized particles (about 10 µm) as a stationary phase led to a considerable improvement of the separation capacity, the time of analysis simultaneously being drastically reduced. This technique, which would frequently generate high pressure drops, was given the name High Performance Liquid Chromatography (HPLC). The introduction of affinity chromatography in HPLC in the late 1970's (Ohlson et al. FEBS Letters 93 (1978) 5), the High Performance Liquid Affinity Chromatography (HPLAC) signified an optimization of the affinity technique, primarily with regard to speed and resolution. However, in comparison with other types of chromatography such as, for example, hydrophobic or ion exchange chromatography it appeared that the efficiency of HPLAC was approximately ten times lower than that of traditional HPLC enabling the generation of 10,000 to 50,000 theoretical plates per m, while the HPLAC technique presents about 100-2,000 theoretical plates per m. The use of more effective carrier material in affinity chromatography such as small-size particles could increase the performance up to a level determined by the molecular interaction per se between the substance and the complementary ligand. In order to optimize the efficiency, i.e. a high degree of resolution, with fully maintained or partly remaining specificity, a completely novel strategy would be required for the choice of ligand, as well as better knowledge as to the design of the separation system. The purpose of the present invention is to achieve an isocratic affinity chromatographic system which is distinguished by high efficiency and short separation time. According to the invention, this object is accomplished with the system defined in the following patent claims and which will be described in more detail below. Biotechnology, Vol. 4 (June 1986) pp 519-521 describes a matrix for quick two-stage affinity chromatography with medium to strong binding between the support media and the ligands. During the first stage the sample molecule forms an equilibrium complex with the immobilised ligand, in the second stage the complex is dissociated and the released molecule is eluted. A process for the recovery of immunoglobulins from milk and blood serum is known through EP-A-0 059 598. In the process, the raw material is passed through an insoluble carrier material with bound monoclonal antibodies specific to one or more milk immunoglobulins. The elution is performed by changing the pH from about neutral to about 2 up to about 10-11 by changing the polarity with ethylene glycol or aqueous dioxan or by electrophoretic desorption. By the nature of this procedure it is likely that the strength of affinity is in the range of medium to high. Contrary to this traditional technique with adsorption followed by elution by changing the conditions in some way, the present invention makes use of a new separation technique where highly reversible weak interactions are used to bind the substance under no or minor change of conditions. Description of the invention For the sake of comprehension it is essential to explain briefly the kinetics for binding the substance (ligate) to ligand and the influence thereof on the chromatographic retention; expressed for example in the capacity factor, k'. Suppose the following simplified conditions which prevail in most cases: The substance (S) binds reversibly and non-convalently to the covalently bound ligand (L) on the surface of the stationary phase. k ass = constant of association rate k diss = constant of dissociation rate, and SL = substance bound on the stationary phase The thermodynamic dissociation (K diss ) is given by where C TOT = conc. of active ligands C SL = conc. of the SL complex C S = conc. of free substance It is further assumed that there are no secondary equilibria present. Assume also that the adsorption isotherm is linear, which means that the chromatographic properties are independent of the substance concentration. Furthermore, we assume that in this performance C TOT -C SL = C TOT . The capacity factor k′ is correlated to equilibrium, constants of rate and concentration of ligands via the equation: Part of the above reasoning has been derived from Chaiken (Anal. Biochem. 97 (1979) 1). In order to reach a resonable retention k₁ = 0.2-50 and preferably k′ = 1-10 in systems characterized by a weak interaction between ligand and ligate, a high ligand concentration (see Equation 3) would be required which is normally the case in ion exchange or hydrophobic chromatography, for example. Band broadening in a chromatographic process is determined by a number of factors such as diffusion of the sample in the mobile and the stationary phase. The theory of this process has been thoroughly investigated by Horvath and Lin (J. Chromatogr., 149 1978) 43) and is briefly discussed in the following. The total band broadening (efficiency) of a substance expressed in H tot (the height of a theoretical plate) is: H tot = H disp + H ext diff + H int diff + H kinetic (4) The first three terms correspond to the non-kinetic contributions to band broadening and represent the spread of the sample in the mobile phase H disp , at the matrix surface H ext diff and within the matrix pores H int diff . These parameters constitute a function of chromatographic and structural conditions such as particle size, sample diffusivity and packing specifications. Generally speaking, the use of smaller particles, high diffusivity in samples and a more even matrix packing are factors contributing to increased efficiency (reduced H tot ). The fourth term, H kinetic , represents band broadening caused by association and dissociation of ligate from its immobilized ligand. It may be shown that H kinetic is proportional to the linear flow rate in the system and inversely proportional to the constant of association rate and dissociation rate, respectively. This means that weak binding (high K diss and high k diss , respectively) will result in reduced H kinetic , i.e. the non-kinetic band broadening effects will dominate the total efficiency (H tot ). In other words, the affinity system characterized by "weak" bindings will make maximum efficiency (minimum H tot ) possible. In these cases band broadening is determined by the non-kinetic elements. In affinity chromatographic applications of today there are utilized moderate up to strong affinities between the immobilized ligand and the interacting substance. The dissociation constant (K diss ) normally lies within the range of 10⁻⁴ to 10⁻¹⁵ M. In most cases this circumstance leads to the chromatographic process becoming an adsorption/desorption technique. In other words, the capacity factor k′ is extremely large, see Equation 3, and may often amount to ten thousands of column volumes. With the employment of such strong affinities in HPLAC using small, about 10 µm rigid particles to minimize the non-kinetic effects, the efficiency is expressed in theoretical plate numbers for example, which are primarily dependent on the inert kinetics between ligand and ligate. The slow dissociation of a ligate from its immobilized ligand plays a leading role here (the constant of dissociation rate, k diss ≈ 10⁻⁵ - 10 sek⁻¹). For weak affinities, K diss > 10⁻³, the rate constants are rapid and equal, whereas for strong affinities the dissociation rate in particular will gradually slow down, the dissociation rate decelerates. In ion exchange or hydrophobic HPLC, for example, the interaction between the stationary phase and the substances is generally based on weak, non-covalent bindings (≈10⁻² > K diss > 0) with high dissociation rates. In many respects, nature's own "communication" between different types of molecules and cells are based on weak affinities. As an example of such molecular interactions can be mentioned the capability of the complementary factor C1Q to differentiate between monomeric immunoglobuline (weak binding: K diss ≈ 10⁻² - 10⁻³ M) and immunocomplex (strong binding: K diss ≈ 10⁻⁶ - 10⁻⁹ M). In this case advantage is taken of the cooperativity involving coaction between several individually weak bindings which together produce a high binding strength (high avidity). Another example is the cell-cell interaction whereby a high surface density of weak binding seats per se (K diss ≈ 10⁻¹ - 10⁻² M) may provide a sufficiently high degree of binding strength between various types of cells. According to the invention there is achieved an affinity chromatographic system wherein the interaction between the immobilized ligand and other substances is characterized by low affinity (K diss > 10⁻³ M). The specificity wanted is attained in that the number of multipe weak interactions with the stationary phase is large enough for enabling the system to discern molecules of no interest, i.e. to differentiate between those totally incapable of binding to the ligand and those having affinity. To reach the inventive results, the properties of the carrier should be such (see below) as to provide high efficiency in the form of a high degree of diffusivity, for example. Also essential is that the nature of the carrier material enables it to bind large volumes of active ligand (> ≈ 1 mM), which demand would be met i.a. by chosing the appropriate carrier porosity, and by supplying mild immobilizing conditions. According to the invention there is created an isocratic affinity chromatographic system wherein the different substances are separated on the basis of their retardation. This could be of vital interest in preparative affinity chromatography involving many times the loss of material by utilizing elution techniques of varying strengths. The immobilized ligand is characterized by being immobilized on a microparticular carrier of preferably porous material which could for example be inorganic materials such as glass or silica, or organic materials such as various types of plastics or polysaccharides. According to the invention, the matrix should be microparticular with a particle size of up to 25 µm, preferably 3-10 µm. The material could have a pore size of up to 1,000 Å, preferably 10-500 Å. The immobilized active ligand is not restricted to any specific type of ligand beyond the demands on properties described above. Examples of such ligands are antibodies or fragments thereof, antigens or fragments thereof, carbohydrates, enzymes with their substrates and inhibitors and receptor-interacting substances. The ligands subjected to previous studies on affinity chromatography were typically characterized by their high affinity when bound to ligates. In the past, ligands suitable for use with the invention were difficult to obtain, but with the development of the so-called hybridome technology for the production of monoclonal antibodies (Köhler and Milstein, Nature, 256 (1975) 495), affinity ligands having a predetermined, low affinity are available today reproducibly and in large amounts. In practice, the tool required to work the invention is now accessible. The immobilization technology employed by the invention has the characteristic feature of effectively binding the ligand covalently while simultaneously maintaining optimal function. As to alternative methods of coupling for immobilizing the ligand, reference is made to Methods in Enzymology, vol. XLIV, 1976. As exemplary methods can be mentioned the coupling of ligands to isocyanate-, isothiocyanate-, mercapto-, epoxy-, aldehyde-, tosyl-, carbonyldiimidazole- and bromocyan-activated matrix, and binding to activated acid and ester groups on the stationary phase. Utilization of the affinit chromatographic system according to the invention is not restricted to applications involving affinity separation exclusively, but combinations with other types of chromatography are also possible; so-called multidimensional chromatography techniques. The invention will be described in the following by means of an exemplary embodiment wherein immobilized monoclonal antibodies are used for the separation of carbohydrate antigens. a) Production of monoclonal antibody covalently immobilized on microparticular silica gel: The monoclonal antibody subjected to study in this example is a mouse IgG2a directed towards a specific carbohydrate determinant. The antibody is selected so as to indicate "weak" affinity towards its epitope (antigen determinant). The weak binding (K diss ≈ 10⁻³ - 10⁻¹ M) will vary in dependence on the physical conditions (pH, temperature, etc.) The antibody is taken from a mouse (ascites) and is purified in several steps (including ammonium sulphate precipitation and protein-A chromatography). The degree of purification is estimated to >95% (electrophoresis) with a remaining antigen-specific activity of >90%. A 10 cm x 5 mm I.D. SelectiSphere-10 Activated Tresyl column (Perstorp Biolytica, Lund, Sweden) was washed with 40 ml of H₂O and 40 ml of 0.2 M NaH₂PO₄, 0.5 M NaCl, pH 7.5 (coupling buffer) at a flow rate of 1.0 ml/min. Immobilization took place in a Shimadzu LC 4 HPLC machine (Japan) equipped with UV detector. A solution of 60 ml monoclonal mouse IgG2a with 2 mg/ml in a coupling buffer containing 0.1 mg/ml of carbohydrate antigen for preventing binding to the antigen binding seat of the antibody was pumped through the column at a rate of 1 ml/min. The column was then washed with 40 ml of coupling buffer and with 60 ml of 0.2 M tris-HCl, pH 8, at 1 ml/min. Protective carbohydrate antigen was eluated with 100 ml of 0.1 M citrate, pH 3.0, at 1 ml/min. All processes were carried out at room temperature, 20-22°C. A reference column without monoclonal mouse IgG2a was prepared analogously as above. The volume of immobilized mouse IgG2a was estimated to 95 mg/g of silica (dry). The immobilized antibody was fully active when bound to its carbohydrate antigen, which would signify that the concentration of active immobilized ligand was approx. 0.8 x 10⁻³ M (two carbohydrate antigens are assumed to bind each antibody). b) Chromatography with monoclonal antibody silica: The columns described above were used in a Varian LC 5500 (USA) with RI/UV detector. All chromatography was carried out at room temperature, 20-22°C, under a normal pressure of 30 ATM at a rate of 1 ml/min. and injection volumes of 10 µl. The mobile phase used was 0.1 M of NaH₂PO₄, pH 7.5. A plurality of different carbohydrate antigens with varying degrees of affinity were studied in the chromatographic system. These carbohydrate antigens were retarded by the column and yielded k′ = 0.3 - 0.8. The retardations attained corresponded to a K diss of 10⁻² - 10⁻³ M. The analysis time was <5 min. The column efficiency for these antigens was estimated to approx. 10⁴ plates per m, or alternatively, to 0.1 mm constituting the height of a theoretical plate. The conclusion reached signifies that the affinity systems described in the foregoing by way of example has high performance expressed in diffusivity and rate. The result should be compared with conventional affinity chromatography operating with plate numbers of approx. 10⁻² - 10⁻³ plates/m. Industrial usage The application of a high performance affinity chromatographic system (HPLAC) characterized by weak interaction with inherent desired selectivity may lead to an upheaval of today's chromatographic techniques. The range of application for separation in its broadest sense will be considerably widened. The usefulness of the invention in this context encompasses analytical and preparative applications for the diagnostic and characterization of molecular interactions, for example, as well as lenient and rapid isolation of e.g. medical substances and diagnostic reagents from various basic media such as fermentation solvents, synthesis media and blood sera.

Claims: Adsorbent for the separation of substances with isocratic affinity chromatography, wherein ligands of antibodies or fragments thereof, antigens or fragments thereof, carbohydrates, enzymes with substrates and inhibitors, receptor-interacting substances etc. are coupled to a stationary, microparticular carrier of inorganic material such as glass or silica or organic material such as different polymers by means of methods known per se with isocyanate, isothiocyanate, mercapto, epoxy, aldehyde, tosyl, tresyl, carbonyldiimidazole and bromcyan-activated matrix and binding to activated acid and ester groups on the stationary phase, characterized in that the ligands are identically alike for achieving an even, weak and uniform bond strength between ligate and ligand with a thermodynamic dissociation constant K diss > 10⁻³ [M], where where k ass = constant of association rate [M⁻¹S⁻¹] k diss = constant of dissociation rate [S⁻¹] C TOT = conc. of active ligands [M] C SL = conc. of the SL complex [M] C S = conc. of free substance [M] S L = substance bound on the stationary phase. Adsorbent according to Claim 1, characterized by a capacity factor wherein the designations have the significance stated above which is = 0.2 - 50. Adsorbent according to Claim 2, characterized in that the capacity factor k' is = 1-10. Adsorbent according to any one of Claims 1-3, characterized in that the ligand consists of a monoclonal antibody or fragments thereof. Method of producing an adsorbent according to Claim 1 with a solid, microparticular carrier and a ligand covalently bound thereto, characterized in that a solution in a coupling buffer of exactly identical ligands and having a binding strength between ligate and ligand with a thermodynamic dissociation constant K diss > 10⁻³ [M] is immobilized on the carrier. Application of adsorbents according to Claim 1 with identical ligands covalently bound to a solid, microparticular carrier having a binding strength between ligates and ligands with a thermodynamic dissociation constant > 10⁻³ for separation in that substances are retarded by the adsorbent and gradually eluted by the sample solution.

Inventors: OHLSON, STEN
Applicants: HYCLONE LABORATORIES, INC.
Application year: 1988
Main classification: C07K3
IPC codes: B01J20, C12Q1, G01N30